{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:41:20Z","timestamp":1791582080265,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["patient-research.elsevier.com","neurobiologyofaging.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.neurobiolaging.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T05:48:59Z","timestamp":1397368139000},"page":"1973-1981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Vanja","family":"Kljajevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Jan","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A\u00a0fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.06.025","article-title":"Head size, age and gender adjustment in MRI studies: a necessary nuisance?","volume":"53","author":"Barnes","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib5","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","article-title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease","volume":"110","author":"Benzinger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2885","article-title":"Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is \u2018too big to fail\u2019","volume":"224","author":"Castellani","year":"2011","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/brain\/awm288","article-title":"Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease","volume":"131","author":"Chetelat","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib9","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","article-title":"Cortical surface-based analysis. I. Segmentation and surface reconstruction","volume":"9","author":"Dale","year":"1999","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib13","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/brain\/awr066","article-title":"Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden","volume":"134","author":"Drzezga","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nicl.2013.10.018","article-title":"Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects","volume":"4","author":"Ewers","year":"2013","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/nimg.1998.0396","article-title":"Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system","volume":"9","author":"Fischl","year":"1999","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neurobiolaging.2012.10.018","article-title":"Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease","volume":"34","author":"Grothe","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib25","doi-asserted-by":"crossref","first-page":"18227","DOI":"10.1523\/JNEUROSCI.3266-12.2012","article-title":"Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging","volume":"32","author":"Jagust","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib27","first-page":"698","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jalz.2012.06.002","article-title":"Biomarker development: a population-level perspective","volume":"8","author":"Khachaturian","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1297.001","article-title":"Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease","volume":"1019","author":"Lee","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0272989X9801800118","article-title":"Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets","volume":"18","author":"Metz","year":"1998","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib34","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1073\/pnas.0914141107","article-title":"Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's","volume":"107","author":"Mosconi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2012.03.002","article-title":"Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents","volume":"34","author":"Mosconi","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib36","first-page":"1778","article-title":"Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease","volume":"47","author":"Mosconi","year":"2006","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00259-012-2237-2","article-title":"A\u00a0European multicentre PET study of fibrillar amyloid in Alzheimer's disease","volume":"40","author":"Nordberg","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib38","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1212\/WNL.0b013e3181e3966e","article-title":"Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline","volume":"74","author":"O'Brien","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/alzrt88","article-title":"Amyloid imaging in prodromal Alzheimer's disease","volume":"3","author":"Ossenkoppele","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.biocel.2008.12.015","article-title":"Reassessing the amyloid cascade hypothesis of Alzheimer's disease","volume":"41","author":"Pimplikar","year":"2009","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/2013.jamaneurol.286","article-title":"Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease","volume":"70","author":"Protas","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib42","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib43","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.04.006_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neeurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014002966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014002966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T20:55:14Z","timestamp":1538686514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0197458014002966"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.04.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}